Vaxart, Inc.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $10.5M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $16.5M |
| SG&A Expense | $10.0M |
| Operating Income | $-18.0M |
| Operating Margin | -171.4% |
| Interest Expense | $1.1M |
| Pretax Income | $-18.7M |
| Income Tax Expense | — |
| Net Income | $-18.7M |
| Net Margin | -178.5% |
| EPS (Basic) | $-0.37 |
| EPS (Diluted) | $-0.37 |
| Shares Outstanding (Basic) | 50.6M |
| Shares Outstanding (Diluted) | 50.6M |
| Dividends Per Share | — |